Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Cowealth Medical China Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥5.41 |
52 Week High | CN¥11.30 |
52 Week Low | CN¥4.71 |
Beta | 0.50 |
11 Month Change | 3.84% |
3 Month Change | -10.73% |
1 Year Change | -35.36% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -10.28% |
Recent News & Updates
Shareholder Returns
603122 | CN Healthcare | CN Market | |
---|---|---|---|
7D | 8.9% | -2.9% | -2.8% |
1Y | -35.4% | -38.1% | -21.0% |
Return vs Industry: 603122 exceeded the CN Healthcare industry which returned -37.8% over the past year.
Return vs Market: 603122 underperformed the CN Market which returned -20.6% over the past year.
Price Volatility
603122 volatility | |
---|---|
603122 Average Weekly Movement | 5.6% |
Healthcare Industry Average Movement | 5.0% |
Market Average Movement | 5.8% |
10% most volatile stocks in CN Market | 9.0% |
10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 603122 has not had significant price volatility in the past 3 months.
Volatility Over Time: 603122's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 240 | Qiongzhi Wang | ch.cowealth.com |
Cowealth Medical China Co.,Ltd. distributes medical products for hospitals in China. The company offers reagents and consumables; in-vitro diagnostic products; and oncology and ophthalmology medical devices.
Cowealth Medical China Co.,Ltd. Fundamentals Summary
603122 fundamental statistics | |
---|---|
Market cap | CN¥2.15b |
Earnings (TTM) | CN¥45.10m |
Revenue (TTM) | CN¥1.06b |
47.8x
P/E Ratio2.0x
P/S RatioIs 603122 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603122 income statement (TTM) | |
---|---|
Revenue | CN¥1.06b |
Cost of Revenue | CN¥844.92m |
Gross Profit | CN¥219.11m |
Other Expenses | CN¥174.01m |
Earnings | CN¥45.10m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 29, 2024
Earnings per share (EPS) | 0.11 |
Gross Margin | 20.59% |
Net Profit Margin | 4.24% |
Debt/Equity Ratio | 10.7% |
How did 603122 perform over the long term?
See historical performance and comparison